The role of gonadotoprins in Alzheimer’s disease: potential neurodegenerative mechanisms

QR Code

The role of gonadotoprins in Alzheimer’s disease: potential neurodegenerative mechanisms

In addition to the classical role of gonadotropins as a modulator of sex hormone production, it is now becoming apparent that the gonadotropins may have actions within the central nervous system. Evidence is also mounting that age-related increases in levels of the gonadotropin, luteinizing hormone...

Full description

Bibliographic Details
Main Authors:	Barron, A., Verdile, Giuseppe, Martins, R.
Format:	Journal Article
Published:	Humana Press 2006
Online Access:	http://hdl.handle.net/20.500.11937/9656

Similar Items

The Link Between Diabetes, Glucose Control, and Alzheimer's Disease and Neurodegenerative Diseases
by: Verdile, Giuseppe, et al.
Published: (2019)

The Role of Luteinizing Hormone in Alzheimer’s Disease
by: Barron, A., et al.
Published: (2010)

Latrepirdine: Molecular mechanisms underlying potential therapeutic roles in Alzheimer’s and other neurodegenerative diseases
by: Bharadwaj, P., et al.
Published: (2013)

Reproductive Hormones Modulate Oxidative Stress in Alzheimer’s Disease
by: Barron, A., et al.
Published: (2006)

A study of the neurodegenerative mechanisms of Alzheimer’s and Huntington’s diseases
by: Parry, Nicholas
Published: (2016)

Immunization in Alzheimer’s disease: Naïve hope or realistic clinical potential?
by: Foster, Jonathan, et al.
Published: (2009)

Zebrafish as a tool in Alzheimer's disease research
by: Newman, M., et al.
Published: (2011)

Molecular Genetics of Alzheimer's Disease
by: Verdile, Giuseppe, et al.
Published: (2009)

The Role of Presenilin and its Interacting Proteins in the Biogenesis of Alzheimer’s Beta Amyloid
by: Verdile, Giuseppe, et al.
Published: (2007)

Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease
by: Martins, I.j, et al.
Published: (2009)

The role of dietary coconut for the prevention and treatment of Alzheimer's disease: potential mechanisms of action
by: Fernando, W., et al.
Published: (2015)

Effect of chronic hCG administration on Alzheimer's-related cognition and Aß accumulation in PS1KI mice
by: Barron, A., et al.
Published: (2010)

Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer’s disease
by: Goozee, K., et al.
Published: (2015)

Carotenoids: Role in Neurodegenerative Diseases Remediation
by: Gandla, Kumaraswamy, et al.
Published: (2023)

Models of Alzheimer’s Disease
by: Chen, M., et al.
Published: (2014)

Research criteria for the diagnosis of Alzheimer’s disease: genetic risk factors, blood biomarkers and olfactory dysfunction
by: Foster, Jonathan, et al.
Published: (2008)

The dynamics of CD147 in Alzheimer's disease development and pathology
by: Kanyenda, L., et al.
Published: (2011)

Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier
by: Asih, P., et al.
Published: (2017)

Understanding haemodynamics in neurodegenerative disease
by: Dury, R.J.
Published: (2018)

Animal Models of Alzheimer's Disease
by: Newman, M., et al.
Published: (2017)

Natural products and their bioactive compounds: neuroprotective potentials against neurodegenerative diseases
by: Mohd Sairazi, Nur Shafika, et al.
Published: (2020)

Clearance mechanisms of Alzheimer’s amyloid-b peptide: implications for therapeutic design and diagnostic tests
by: Bates, K., et al.
Published: (2009)

Assessing genetic overlap of Alzheimer’s disease with type 2 diabetes
by: Adewuyi, Emmanuel, et al.
Published: (2025)

Inflammation in Alzheimer's Disease, and Prevention with Antioxidants and Phenolic Compounds – What Are the Most Promising Candidates?
by: Sharman, M., et al.
Published: (2019)

Alzheimer's disease-related peptide PS2V plays ancient, conserved roles in suppression of the unfolded protein response under hypoxia and stimulation of ?-secretase activity
by: Nik, S., et al.
Published: (2015)

Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer’s disease
by: Verdile, Giuseppe, et al.
Published: (2015)

The role of endocannabinoids in Alzheimer's disease
by: Maroof, Nazia
Published: (2013)

Evidence for and against a pathogenic role for reduced γ-secretase activity in familial Alzheimer’s disease
by: Verdile, Giuseppe, et al.
Published: (2016)

The role of gonadotropins and testosterone in the regulation of beta amyloid metabolism
by: Verdile, Giuseppe, et al.
Published: (2009)

Yeast as a model for studying Alzheimer's disease
by: Bharadwaj, Prashant, et al.
Published: (2010)

SFRP-mediated Wnt sequestration as a potential therapeutic target for Alzheimer's disease
by: Warrier, Sudha, et al.
Published: (2016)

Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
by: Pike, K., et al.
Published: (2011)

An interactive review on the role of Tocotrienols in the neurodegenerative disorders
by: Naomi, Ruth, et al.
Published: (2021)

Ovariectomy and 17ß-estradiol replacement do not alter ß-amyloid levels in sheep brain
by: Barron, A., et al.
Published: (2009)

Predicting memory decline as a risk factor for Alzheimer’s disease in older post-menopausal women: quod erat demonstrandum?
by: Rodrigues, M., et al.
Published: (2010)

Modulatory effect of mild inflammation on tau phosphorylation in a human tau mouse model of Alzheimer's disease
by: Barron, Matthew
Published: (2018)

Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians.
by: Asih, P., et al.
Published: (2014)

The role of type 2 diabetes in neurodegeneration
by: Verdile, Giuseppe, et al.
Published: (2015)

Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases
by: Muñoz-Lobato, Fernando, et al.
Published: (2014)

Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease
by: Gnjec, A., et al.
Published: (2008)